|
|
SPOT ON
|
|
Will the ban on direct-to-consumer-advertising ("DTCA") for prescription drugs be lifted?
|
|
|
NEW ON THE MARKET
|
|
New oral antidiabetic: DPP-IV-inhibitor Sitagliptin (JANUVIA)
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
HPV-vaccine GARDASIL: benefit overestimated?
|
|
Memantine (AXURA, EBIXA) for ALZHEIMER disease: negative results suppressed
|
|
|
BEWARE MISINFORMATION
|
|
"M2-PK" - no outmatching screening marker for colonic cancer
|
|
|
QUALITY CONTROL
|
|
Amitriptyline-preparations (SAROTEN TABS u.a.): good qualitiy
|
|
|
IN BRIEF
|
|
Elsevier: publisher for medical literature retires from business with weapons
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Facial edemas due to anti-obesity drug rimonabant (ACOMPLIA)
|
|
|
SIDE EFFECTS
|
|
Antidiabetic rosiglitazone (AVANDIA): suspicion of cardiotoxicity aggravated
|
|